Preparation, Characterization and In Vitro Release Study of Microcapsule Simvastatin Using Biodegradable Polymeric Blend of Poly(L-Lactic Acid) and Poly(ɛ-Caprolactone) with Double Emulsifier

Abstract:

Simvastatin is a cholesterol-lowering agent that inhibits the microsomal activity of 3-hydroxy-3-methylglutaril-CoA-reductase (HMG-CoA reductase), enzyme that contributes in biosynthesis cholesterol. Simvastatin has short half-life elimination about 2 hours and low solubility, this condition makes its bioavailability to be quite small. Simvastatin has adverse effect such as myopathy and rhabdomyolysis because of higher dose consumption of simvastatin. Controlled drug delivery system is needed to reduce the adverse effect. One of method that is used in drug delivery system is encapsulation using biodegradable polymer such as poly(L-lactic acid) and poly(ɛ-caprolactone). PLLA and PCL was blended with fix composition PLLA : PCL 60 : 40 (%w/w) by solvent evaporation technique using Tween 80 and Span 80 as emulsifier. Based on the optimization, the best encapsulation efficiency microcapsules were obtained at concentration of Tween 80 0.025% (v/v), Span 80 1% (v/v) with stirring speed at 900 rpm for 1 hour. The encapsulation efficiency was 83.67%. The best microcapsules were dissolved in dissolution media to get drug release profile. The percentage of drug release at pH 1.2 was 0.86% for 3 hours and in the phosphate buffer solution pH 7.4 for 12.22% for 52 hours.

• Periodical: Materials Science Forum (Volume 977)
• Pages: 178-183
• DOI: https://doi.org/10.4028/www.scientific.net/MSF.977.178
• Online since: February 2020
• Authors: Findi Citra Kusumasari, Lukmanul Hakim Samada, Emil Budianto*
• Keywords: Dissolution, Encapsulation Efficiency, Microcapsule, O/W Solvent Evaporation, Poly(ɛ-Caprolactone), Poly(L-Lactic Acid), Simvastatin, Span 80, Tween 80

References

[1] J.E.F. Reynolds, Martindale, The Extra Pharmacopoeia, thirtieth ed., The Pharmaceutical Press, London, (1993).

[2] P. D. Thompson, P. Clarkson, and R. H. Karas, Statin-Associated Myopathy, Journal of the American Medical Association, 289 (2003) 1681-1690.

[3] Y. Sun, Y. Peng, Y. Chen, and A. J. Shukla, A pplication of artificial neural networks in the design of.pdf, Adv. Drug Deliv. Rev, 55 (2003) 1201–1215.

[4] C. Thies, Microencapsulation, Encyclopedia of Polymer Science and Technology., John Wiley & Sons, Inc.2005 p.1–29.

[5] X. Qi, Y. Ren, and X. Wang, New advances in the biodegradation of Poly(lactic) acid, International Biodeterioration and Biodegradation, 117 (2017) 215–223.

DOI: 10.1016/j.ibiod.2017.01.010

[6] T. Kemala, E. Budianto, and B. Soegiyono, Preparation and characterization of microspheres based on blend of poly(lactic acid) and poly(ε-caprolactone) with poly(vinyl alcohol) as emulsifier, Arab. J. Chem, 5 (2012) 103–108.

DOI: 10.1016/j.arabjc.2010.08.003

[7] S. Tiwari and P. Verma, Microencapsulation technique by solvent evaporation method (Study of effect of process variables), International J. Pharm. Life Sci, 2 (2011) 998–1005.

[8] S. Mohammadi-Samani and B. Taghipour, PLGA micro and nanoparticles in delivery of peptides and proteins; Problems and approaches, Pharm. Dev. Technol, 20(2015) 385–393.

DOI: 10.3109/10837450.2014.882940

[9] M. E. Q. Raymond C Rowe, Paul J S, Handbook od pharmaceutical excipients. (2009).

[10] B. A. Kerwin, Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways, J. Pharm. Sci, 97 (2008) 2924–2935.

DOI: 10.1002/jps.21190

[11] N. T. Hwisa, P. Katakam, B. R. Chandu, and S. K. Adiki, Solvent Evaporation Techniques as Promising Advancement in Microencapsulation, Vedic Res. Int. Biol. Med. Chem, 1 (2013).

DOI: 10.14259/bmc.v1i1.29

[12] L. Francis, D. Meng, J. Knowles, and T. Keshavarz, Controlled Delivery of Gentamicin Using Poly ( 3-hydroxybutyrate ) Microspheres, Int. J. Mol. Sci, 12 (2011) 4294–4314.

DOI: 10.3390/ijms12074294

[13] S. Nilkumhang and A. W. Basit, The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles, Int. J. Pharm, 377 (2009) 135–141.

DOI: 10.1016/j.ijpharm.2009.03.024

[14] N. Sharma, P. Madan, and S. Lin, Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: A co-surfactant study, Asian J. Pharm. Sci, 11 (2016) 404–416.

DOI: 10.1016/j.ajps.2015.09.004

[15] R. Dinarvand, S. H. Moghadam, A. Sheikhi, and F. Atyabi, Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique, J. Microencapsul, 22 (2005) 139–151.

DOI: 10.1080/02652040400026392

[16] J. Joshi and R. Patel, Role of Biodegradable Polymers in Drug Delivery, Int. J. Curr. Pharm. Res, 4 (2012) 74–81.

[17] M. Sailaja, Abbaraju Krishna and Jyothika, A review on microcapsules, CIBTech J. Pharm. Sci, 9 (2015) 198–203.

[18] K. Dashora, S. Saraf, and S. Saraf, Effect of processing variables and in-vitro study of microparticulate system of nimesulide, Rev. Bras. Ciências Farm, 43 (2008) 555–562.

DOI: 10.1590/s1516-93322007000400008

[19] I. Biswal, A. Dinda, S. Mohanty, M. Dhara, D. Das, and K. . Chowdary, Influence of Drug / Polymer Ratio on the Encapsulation Efficiency of Highly Hydrophilic Drug, Asian J. Chem, 23(2011) 1973–(1978).

[20] Y. Yeo and K. Park, Control of Encapsulation Efficiency and Initial Burst in Polymeric Microparticle Systems, Arch. Pharmacal Res, 27 (2004) 1–12.

DOI: 10.1007/bf02980037

[21] R. Seeley, C. VanPutte, J. Regan, T. Stephens, P. Tate, and A. Russo, Large Intestine Objective, Seeley's Anat. Physiol, 864 (2013) 860–910.

[22] F. Alexis, Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)], Polymer International, 54 (2005) 36–46.

DOI: 10.1002/pi.1697

[23] Y. Javadzadeh, S. M. Dizaj, Z. Vazifehasl, and M. Mokhtarpour, Recrystallization of Drugs-Effect on Dissolution Rate, Recrystallization in Materials Processing, (2015) 191–211.

DOI: 10.5772/60006

[24] D. Klose, F. Siepmann, K. Elkharraz, S. Krenzlin, and J. Siepmann, How porosity and size affect the drug release mechanisms from PLGA-based microparticles, Int. J. Pharm, 314, (2006) 198–206.

DOI: 10.1016/j.ijpharm.2005.07.031